Efficacy and Safety of Sertraline in Treating Pruritus in Liver Disease Patients: Case Reference Study

Publish Year: 1402
نوع سند: مقاله ژورنالی
زبان: English
View: 55

This Paper With 8 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_JMCH-6-5_018

تاریخ نمایه سازی: 29 آبان 1401

Abstract:

Background: One of the common clinical manifestations in patients with chronic liver disease is the symptom of pruritus which has been reported in about ۸۰ to ۱۰۰ %. In a subset of patients, nearly ۱۰ to ۲۰ %, the symptom becomes refractory and can lead to depression, inability to sleep, and even suicidal attempts. Aim of the study: The aim of the current study was to evaluate efficacy and safety of sertraline in treatment of pruritus associating chronic liver disease, diabetes mellitus, and atopic dermatitis.Patients and methods: Sertraline was given at dose (۷۵-۱۰۰ mg/day) to all enrolled patients for ۱۲ weeks. During this period patients were followed up for side effects.Results: The highest rate was seen in chronic liver disease, patients followed by diabetes mellitus, and then by atopic dermatitis. Comparison of rate of satisfactory response among the study groups revealed no significant difference between chronic liver disease group and diabetes mellitus group (p = ۰.۶۴۳). Whereas, the rate was significantly higher in patients with chronic liver disease in comparison with control group (p = ۰.۰۳۳). Conclusion: Sertraline is an efficient and safe pharmacological agent for relief of pruritus not only in patients with chronic liver disease, in whom it has the best rate of satisfactory response, but also in other disorders such as diabetes mellitus and to a lesser extent atopic dermatitis.

Authors

Hussam H. Sahib

Department of Clinical Laboratory Sciences, College of Pharmacy, University of Al-Qadisiyah, Diwaniya, Iraq

Ahmed M Sultan Sultan

Department of Pharmacology and Therapeutics, College of Medicine, University of Al-Qadisiyah, Diwaniya, Iraq

Asma A. Swadi

Department of Pharmacology and Therapeutics, College of Medicine, University of Al-Qadisiyah, Diwaniya, Iraq

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :